| Neuraxpharm Switzerland AG - Tranxilium 50 mg, Filmtabletten | | 45388 | | 01 | | Tranxilium 50 mg | | Filmtabletten | | N05BA05 | | Dikaliumclorazepat | | 03.04.1984 | | |
| | Composition | | dikalii clorazepas 50 mg, E 127, lactosum 52.88 mg, magnesii stearas, talcum, kalii carbonas, kalii chloridum, magnesii oxidum leve, polacrilinum kalicum, ricini oleum hydrogenatum, Überzug: copolymerum methacrylatis butylati basicum, diethylis phthalas, E 127, E 171, talcum pro compresso obducto. | | Packungsbestandteile | | Comprimés filmés | | | | Principe actif | Concentr. |
|---|
| Clorazepat-Dikalium | 50 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| Copolymerum Methacrylatis Butylati Basicum | | Überzug | | Diethylis Phthalas | | | | E 127 | | color. | | E 171 | | color. | | Potassium Carbonate | | | | Potassium Chlorure | | | | Lactosum | 52.88 mg | | | Magnesium Oxide Léger | | | | Magnesii Stearas | | | | Polacrilinum Kalicum | | | | Ricini Oleum Hydrogenatum | | | | Talcum | | | | Talcum pro Compresso Obducto | | |
|
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 050 | 30 Comprimé(s) | DDP | DDP | B | | Oui |
|
|
